Responses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapy

Madeleine DuvicThe University of Texas MD Anderson Cancer Center, Houston, TX, USA; Correspondence[email protected]

Susan E. BatesDepartment of Hematology/Oncology, Columbia University, New York, NY, USA;

Richard PiekarzCancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA; View further author information

Robin EischNational Cancer Institute, Bethesda, MD, USA; View further author information

Youn H. KimDepartment of Dermatology, Stanford University, Stanford, CA, USA; View further author information

Tadeusz RobakDepartment of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland; View further author information

Alexey SamtsovState Educational Institution of Military Medicine, St. Petersburg, Russia; View further author information

Jürgen C. BeckerTranslational Skin Cancer Research, German Cancer Consortium (DKTK), University Clinic Essen, Germany; View further author information

Joel WaksmanBrightech International LLC, Somerset, NJ, USA; View further author information

Your download is now in progress and you may close this window